Precision Diagnostics for Transplant Care
CareDx (caredx.com) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, in the 70th percentile of 11814 Healthcare brands.
CareDx is a healthcare and SaaS company founded in 2000 and headquartered in Brisbane, California. It specializes in precision medicine for transplant and specialty oncology patients, offering molecular diagnostics, digital health tools, workflow solutions, patient services, and pharmacy support. The company serves transplant clinicians, specialty care teams, patients undergoing transplant or cell therapy, and healthcare investors, positioning itself as a leading provider dedicated exclusively to transplant and specialty oncology care across the full patient journey.
| Brand Name | CareDx |
|---|---|
| Domain | caredx.com |
| Industry | Healthcare, SaaS |
| Founded | 2000 |
| Headquarters | Brisbane |
| Main Competitors | Natera (85/100), Thermo Fisher Scientific (90/100), Eurofins Transplant Genomics, Immucor (76/100), Veracyte (83/100) |
Moz Domain Authority 45/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #244,176 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CareDx delivers transplant-focused diagnostics, digital health tools, and services that support patients and clinicians across the entire transplant journey." (Meta description: 19 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, Product/Article schema. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel, WordPress.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram, YouTube, GitHub; no detected presence on X (Twitter) - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is CareDx?", Claude could identify the brand as of September 2026. CareDx is a healthcare company specializing in transplant medicine, best known for developing molecular diagnostics like AlloSure, a blood test that detects donor-derived cell-free DNA to monitor organ transplant rejection. The company also offers other testing services and digit Best known for AlloSure, a non-invasive blood test for detecting organ transplant rejection using donor-derived cell-free DNA.
When asked "Best brands similar to CareDx?", Claude would recommend CareDx as of September 2026. CareDx is a leading and well-recognized name in transplant diagnostics, so it would naturally come up if discussing companies focused on organ transplant monitoring or precision diagnostics in healthcare.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CareDx's main competitors in Healthcare: Natera (85/100), Thermo Fisher Scientific (90/100), Immucor (76/100), Veracyte (83/100).
Sources: Brand Analyzer scan
CareDx offers molecular testing (diagnostics), digital health tools, workflow tools for clinicians, patient services, and pharmacy support, all tailored to the needs of transplant, cell therapy, and specialty oncology patients across their care journey.
Sources: CareDx official site
CareDx is a healthcare and SaaS company, founded in 2000 and headquartered in Brisbane, California, that specializes in precision medicine for transplant and specialty oncology patients. It is described as a medical transplant company that delivers connected diagnostic and digital health solutions across the entire transplant patient journey.
Sources: CareDx official site
CareDx has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 39, recommendation 59). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CareDx official site
CareDx was founded in 2000. CareDx operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CareDx is headquartered in Brisbane. CareDx operates in the Healthcare category.
Sources: Wikidata
CareDx delivers transplant-focused diagnostics, digital health tools, and services that support patients and clinicians throughout the entire transplant journey. It combines molecular testing, workflow tools, patient services, and pharmacy support to address the complex needs of transplant, cell therapy, and specialty oncology care, backed by clinical evidence.
Sources: CareDx official site
CareDx scores 59/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CareDx official site
CareDx can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CareDx official site
CareDx is used by transplant clinicians, specialty care teams, patients undergoing transplant or cell therapy, and healthcare investors.
Sources: CareDx official site
CareDx is known for being a precision medicine company dedicated exclusively to transplant and specialty oncology care, offering molecular diagnostic testing combined with digital health and workflow tools for the entire transplant patient journey.
Sources: CareDx official site
CareDx scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CareDx has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (59/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #244,176 (Tranco) and a Moz Domain Authority of 45/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CareDx from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CareDx: CareClix (80/100), Canadian Association of Radiologists (CAR) (80/100), CareFlite (80/100), Caregility (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.